Novartis partners with American Society of Hematology to fight Sickle Cell Disease in Sub-Saharan Africa Read more
US FDA approves Novartis Kymriah CAR-T cell therapy for adult patients with relapsed or refractory Follicular Lymphoma Read more
Novartis and Voyager Therapeutics reach licence option agreement for next-generation gene therapy vectors for neurological diseases Read more
Novartis and Molecular Partners report positive topline data from phase-II study for Ensovibep Read more
Schneider Electric launches programme to increase access to renewable energy for pharmaceutical suppliers Read more
